ARID1A and ovarian carcinoma: Recently, new clinical treatment methods have been developed, including immune checkpoint blockade therapy, targeted angiogenesis therapy, the use of ARID1A synthesis for lethal interactions, and targeting liver cell nucleus factor 1 β New therapies such as ferroptosis bring great hope to ovarian cancer patients.26